MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/03/6405-1169-1179$20.00
Mol Pharmacol 64:1169-1179, 2003

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chung, S. W.
Right arrow Articles by Kim, T. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chung, S. W.
Right arrow Articles by Kim, T. S.

Inhibition of Interleukin-4 Production in CD4+ T Cells by Peroxisome Proliferator-Activated Receptor-{gamma} (PPAR-{gamma}) Ligands: Involvement of Physical Association between PPAR-{gamma} and the Nuclear Factor of Activated T Cells Transcription Factor

Su Wol Chung, Bok Yun Kang, and Tae Sung Kim

College of Pharmacy and Research Institute of Drug Development, Chonnam National University, Kwangju, Republic of Korea (S.W.C., T.S.K.); and Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts (B.Y.K.)

Peroxisome proliferator-activated receptor-{gamma} (PPAR-{gamma}) has been implicated in the regulation of multiple inflammatory processes. However, little is known of PPAR-{gamma} in the regulation of interleukin (IL)-4 expression in T cells. In this study, the effects of PPAR-{gamma} ligands on production of IL-4, a pro-inflammatory cytokine associated with the pathophysiology of allergic diseases, were investigated. 15-Deoxy-{Delta}12,14 prostaglandin J2 (15d-PGJ2) and ciglitazone, two representative PPAR-{gamma} ligands, significantly inhibited IL-4 production in both antigen-stimulated primary CD4+ T cells and the phorbol 12-myristate 13-acetate (PMA)/ionomycin-activated EL-4 T cell line. 15d-PGJ2 and ciglitazone inhibited the activation of IL-4 gene promoter in EL-4 T cells transiently transfected with IL-4 promoter/reporter constructs, and the repressive effect mapped to a region in the IL-4 promoter containing binding sites for nuclear factor of activated T cells (NF-AT). The activation of T cells by PMA/ionomycin resulted in a marked enhancement of the binding activities to the NF-AT site that was significantly inhibited by the addition of PPAR-{gamma} ligands. In cotransfected EL-4 T cells, PPAR-{gamma} also inhibited the activation of the IL-4 promoter at multiple NF-AT sites in a ligand-dependent manner. NF-ATc1 bound PPAR-{gamma} both in vivo and in vitro, and the interaction interfaces involved the Rel similarity domain of NF-ATc1. In cotransfections of HeLa cells, PPAR-{gamma} inhibited the NF-ATc1 transactivation in a ligand-dependent manner. Coexpression of p300 or AP-1 relieved the PPAR-{gamma} ligand-mediated inhibition of the NF-AT transactivation. From these results, we propose that PPAR-{gamma} ligand-mediated suppression of IL-4 production in CD4+ T cells may involve both inhibition of the NFAT-DNA interactions and competitive recruitment of transcription integrators between NF-AT and PPAR-{gamma}.


Received April 23, 2003; accepted August 5, 2003

Address correspondence to: Dr. Tae Sung Kim, College of Pharmacy and Research Institute of Drug Development, Chonnam National University, Kwangju 500-757, Republic of Korea. E-mail: taekim{at}chonnam.ac.kr




This article has been cited by other articles:


Home page
Toxicol SciHome page
X. Fang, L. Zhang, Y. Feng, Y. Zhao, and J. Dai
Immunotoxic Effects of Perfluorononanoic Acid on BALB/c Mice
Toxicol. Sci., October 1, 2008; 105(2): 312 - 321.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Fionda, F. Nappi, M. Piccoli, L. Frati, A. Santoni, and M. Cippitelli
Inhibition of Trail Gene Expression by Cyclopentenonic Prostaglandin 15-Deoxy-{Delta}12,14-Prostaglandin J2 in T Lymphocytes
Mol. Pharmacol., November 1, 2007; 72(5): 1246 - 1257.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Hontecillas and J. Bassaganya-Riera
Peroxisome Proliferator-Activated Receptor {gamma} Is Required for Regulatory CD4+ T Cell-Mediated Protection against Colitis
J. Immunol., March 1, 2007; 178(5): 2940 - 2949.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
A. von Knethen, M. Soller, N. Tzieply, A. Weigert, A. M. Johann, C. Jennewein, R. Kohl, and B. Brune
PPAR{gamma}1 attenuates cytosol to membrane translocation of PKC{alpha} to desensitize monocytes/macrophages
J. Cell Biol., February 26, 2007; 176(5): 681 - 694.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
J. Zhang, M. A. Alston, H. Huang, and R. L. Rabin
Human T cell cytokine responses are dependent on multidrug resistance protein-1
Int. Immunol., March 1, 2006; 18(3): 485 - 493.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Aceves, A. Duenas, C. Gomez, E. San Vicente, M. S. Crespo, and C. Garcia-Rodriguez
A New Pharmacological Effect of Salicylates: Inhibition of NFAT-Dependent Transcription
J. Immunol., November 1, 2004; 173(9): 5721 - 5729.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Mathew, E. Mascareno, and M. A. Q. Siddiqui
A Ternary Complex of Transcription Factors, Nished and NFATc4, and Co-activator p300 Bound to an Intronic Sequence, Intronic Regulatory Element, Is Pivotal for the Up-regulation of Myosin Light Chain-2v Gene in Cardiac Hypertrophy
J. Biol. Chem., September 24, 2004; 279(39): 41018 - 41027.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
K. C. Switzer, Y.-Y. Fan, N. Wang, D. N. McMurray, and R. S. Chapkin
Dietary n-3 polyunsaturated fatty acids promote activation-induced cell death in Th1-polarized murine CD4+ T-cells
J. Lipid Res., August 1, 2004; 45(8): 1482 - 1492.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics